Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Linda Kaplan who wrote (5360)	8/26/1998 2:43:00 PM
From: Linda Kaplan	Read Replies (2) \| Respond to of 7041

The time is now. 16-11/16. <clink!> Linda

To: Linda Kaplan who wrote (5360)	8/26/1998 5:33:00 PM
From: George Acton	Read Replies (1) \| Respond to of 7041

\| I wonder when, or should I say, at what time, ZONA will drop \| through 17? Any thoughts on how long it can hang there? I'm an idiot concerning any kind of market timing. I think that in the real world, the FDA could send them a letter saying that Vasomax doesn't qualify for serious review, and that could come in a few weeks to a few months. Obviously, the effect on the share price would not be favorable. If the FDA sends it to a review panel it could take months for a definitive answer. In that case, the company has enough cash to operate for a long time and hopes for approval could keep the price up. Other considerations such as the total size of the market, patient satisfaction with Viagra and the success or failure of other ED drugs would affect the prospects for Vasomax and the price. --George Acton